Interestingly, a novel monoterpene glycoside named ESK246, derived from the plant Pittosporum venulosum, suppresses prostate cancer cell proliferation by inhibiting LAT-3 and subsequently mTORC1 signaling [214]. Here, SLC7A7 is linked to prostate carcinoma.